| 中國文化大學 |
2010-12 |
Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals
|
Wu, S (Wu, Semon); Hsu, LA (Hsu, Lung-An); Teng, MS (Teng, Ming-Sheng); Lin, JF (Lin, Jeng Feng); Chang, HH (Chang, Hsien-Hsun); Chang, PY (Chang, Pi-Yueh); Hu, CF (Hu, Chiao-Feng); Ko, YL (Ko, Yu-Lin) |
| 中山醫學大學 |
2014-07-19 |
Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma.
|
CW, Lin; SF, Yang; CY, Chuang; HP, Lin; CH, Hsin |
| 亞洲大學 |
2018-04 |
Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan
|
Liang-Chun, S;Shih, Liang-Chun;Li, Ching-Hao;Li, Ching-Hao;Sun, Kuo-Ting;Sun, Kuo-Ting;Che, Liang-Yu;Chen, Liang-Yu;Hsu, Che-Lun;Hsu, Che-Lun;Hung, Yi-Wen;Hung, Yi-Wen;Wu, Cheng-Nan;Wu, Cheng-Nan;Hsia, Te-Chun;Hsia, Te-Chun;Shen, Te-Chun;Shen, Te-Chun;Cha, Wen-Shin;Chang, Wen-Shin;Sh, Tzu-Ching;Shih, Tzu-Ching;Tsa, Chia-Wen;Tsai, Chia-Wen;包大?;Bau, Da-Tian;* |
| 亞洲大學 |
2018-10 |
Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer
|
LI, CHENG-HSI;LIAO, CHENG-HSI;CHA, WEN-SHIN;CHANG, WEN-SHIN;TSA, CHIA-WEN;TSAI, CHIA-WEN;HU, PEI-SHIN;HU, PEI-SHIN;WU, HSI-CHIN;WU, HSI-CHIN;HSU, SHIH-WEI;HSU, SHIH-WEI;GUAN-LIANG, C;CHEN, GUAN-LIANG;YUE, TE-CHENG;YUEH, TE-CHENG;SHEN, TE-CHUN;SHEN, TE-CHUN;HSIA, TE-CHUN;HSIA, TE-CHUN;包大?;Bau, Da-Tian |
| 亞洲大學 |
2018-09 |
Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer
|
TSUNG-HSUN, TSUNG-HSUN T;TSAI, TSUNG-HSUN;WAN, YAO-MING;WANG, YAO-MING;CHA, WEN-SHIN;CHANG, WEN-SHIN;TSA, CHIA-WEN;TSAI, CHIA-WEN;WU, HSI-CHIN;WU, HSI-CHIN;HSU, HUAI-MEI;HSU, HUAI-MEI;WANG, YUN-CHI;WANG, YUN-CHI;LI, HSIN-TING;LI, HSIN-TING;GONG, CHI-LI;GONG, CHI-LI;包大?;Bau, Da-Tian |
| 中山醫學大學 |
2004 |
Association of matrix metalloproteinase-9 and Purkinje cell degeneration in mouse cerebellum caused by Angiostrongylus cantonensis.
|
Chen, KM; Lee, HH; Lu, KH; Tseng, YK; Hsu, LS; Chou, HL; Lai, SC |
| 中山醫學大學 |
2004 |
Association of matrix metalloproteinase-9 in eosinophilic meningitis of BALB/c mice caused by Angiostrongylus cantonensis.
|
Lee, HH; Chou, HL; Chen, KM; Lai, SC |
| 亞洲大學 |
2019-12 |
Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk
|
MING-HSIEN, W;WU, MING-HSIEN;TZEN, HUEY-EN;TZENG, HUEY-EN;WU, CHENG-NAN;WU, CHENG-NAN;YUE, TE-CHENG;YUEH, TE-CHENG;PEN, YEN-CHUN;PENG, YEN-CHUN;TSA, CHUN-HAO;TSAI, CHUN-HAO;WANG, YUN-CHI;WANG, YUN-CHI;KE, TAO-WEI;KE, TAO-WEI;PE, JEN-SHENG;PEI, JEN-SHENG;CHA, WEN-SHIN;CHANG, WEN-SHIN;包大?;Bau, Da-Tian |
| 臺大學術典藏 |
2017 |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Guo J.-C.; JEN-CHIEH LEE; Yang S.-H.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2018-09-10T18:05:09Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang, S.-H.;Lee, J.-C.;Guo, J.-C.;Kuo, S.-H.;Tien, Y.-W.;Kuo, T.-C.;Cheng, A.-L.;Yeh, K.-H.; TING-CHUN KUO; YU-WEN TIEN; JEN-CHIEH LEE; ANN-LII CHENG |
| 臺大學術典藏 |
2020-02-20T06:53:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; YU-WEN TIEN; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2017 |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yeh K.-H.; Cheng A.-L.; Kuo T.-C.; Tien Y.-W.; Kuo S.-H.; JEN-CHIEH LEE; Guo J.-C.; Yang S.-H.; Yang S.-H.;Jen-Chieh Lee;Guo J.-C.;Kuo S.-H.;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Yeh K.-H. |
| 臺大學術典藏 |
2020-09-29T06:53:03Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yeh K.-H.; Cheng A.-L.; TING-CHUN KUO; Tien Y.-W.; Kuo S.-H.; Guo J.-C.; Lee J.-C.; Yang S.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:22Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.;Lee J.-C.;Guo J.-C.;Kuo S.-H.;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Kun-Huei Yeh; Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-08-12T04:01:25Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
YANG SHIH-HUNG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-18T07:39:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; JHE-CYUAN GUO; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:35Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:04Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-02-23T08:26:17Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.;Lee J.-C.;Guo J.-C.;Sung-Hsin Kuo;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Yeh K.-H.; Yang S.-H.; Lee J.-C.; Guo J.-C.; SUNG-HSIN KUO; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-10T03:53:03Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 國立成功大學 |
2023-4 |
Association of medications with burning mouth syndrome in Taiwanese aged patients
|
吳昱學; WU, YU-HSUEH; Wu, Yu-Hsueh;Chiang, Chun-Pin |
| 國立成功大學 |
2023 |
Association of medications with burning mouth syndrome in Taiwanese aged patients
|
Wu, Y.-H.;Chiang, Chiang C.-P. |
| 中國醫藥大學 |
2015-10 |
Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case-Control Study.
|
賴世偉(Shih-Wei Lai);林橙莉;廖光福(Kuan-Fu Liao)* |
| 國立臺灣大學 |
2010 |
Association of Metabolic Profiles with Hepatic Fibrosis in Chronic Hepatitis C Patients with Genotype 1 or 2 Infection
|
許景盛; 劉振驊; 劉俊人; 徐士哲; 陳祈玲; 黃瑞仁; 賴明陽; 陳培哲; 陳定信; 高嘉宏; HSU, CHING-SHENG; LIU, CHEN-HUA; LIU, CHUN-JEN; HSU, SHIH-JER; CHEN, CHI-LING; HWANG, JUEY-JEN; LAI, MING-YANG; CHEN, PEI-JER; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2022-01-24T09:32:00Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; CHUN-JEN LIU; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
